Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...

It’s a move that could alter care for millions of women and significantly affect those across the Brazos Valley, especially ...

The test, which will use Iso-PAS technology, will be developed by Nipro of Japan in collaboration with other companies, institutes, and nonprofit organizations.

REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker innovation, announced today the presentation of seven studies at the upcoming ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

At the meeting, researchers shared real-world data showing ctDNA positivity at the end of treatment was prognostic across lymphoma subtypes and better than PET scans.

OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation File for FDA Emergency Use Authorization for COVID-19 Detection Test Utilizing ...

Women at average risk for cervical cancer can avoid unpleasant tests in doctors' offices and instead safely test themselves at home for the virus that causes nearly all cases of the disease, the ...

Please refer to the ASH 2025 online program for full session details and visit the Genetix booth (#1261) onsite.

That observation was prompted by a visit to the walk-in storage cooler inside the Blood Bank in UAB Hospital. If you are squeamish at the sight of blood, this is not the place for you. When the door ...

Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...